LINE-1 Retroelements Complexed and Inhibited by Activation Induced Cytidine Deaminase

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Metzner, Mirjam ^a,b   Jäck, Hans Martin ^b   Wabl, Matthias ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B; COMPLEMENTARY DNA; DEOXYRIBONUCLEOPROTEIN; MESSENGER RNA; OPEN READING FRAME 1; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; IN VITRO STUDY; LONG INTERSPERSED NUCLEAR ELEMENT 1; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RETROPOSON; STEADY STATE; WESTERN BLOTTING;

ANIMALS; CELL LINE; CHROMATOGRAPHY, LIQUID; CYTIDINE DEAMINASE; DNA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEK293 CELLS; HELA CELLS; HUMANS; LIPOPOLYSACCHARIDES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MICE; MICE, INBRED BALB C; MUTATION; OPEN READING FRAMES; RETROELEMENTS; SPLEEN;

MURINE LEUKEMIA VIRUS; MUS;

EID: 84868325404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049358     Document Type: Article

References (68)

1. Delker RK, Fugmann SD, Papavasiliou FN, (2009) A coming-of-age story: activation-induced cytidine deaminase turns 10. Nat Immunol 10: 1147-1153.
2. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
3. Wang CL, Harper RA, Wabl M, (2004) Genome-wide somatic hypermutation. Proc Natl Acad Sci U S A 101: 7352-7356.
4. Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451: 841-845.
5. Popp C, Dean W, Feng S, Cokus SJ, Andrews S, et al. (2010) Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463: 1101-1105.
6. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, et al. (2010) Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463: 1042-1047.
7. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
8. Prochnow C, Bransteitter R, Chen XS, (2009) APOBEC deaminases-mutases with defensive roles for immunity. Sci China C Life Sci 52: 893-902.
9. Conticello SG, (2008) The AID/APOBEC family of nucleic acid mutators. Genome Biol 9: 229.
10. Kinomoto M, Kanno T, Shimura M, Ishizaka Y, Kojima A, et al. (2007) All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 35: 2955-2964.
11. Goodier JL, Kazazian HH Jr, (2008) Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135: 23-35.
12. Deininger PL, Moran JV, Batzer MA, Kazazian HH Jr, (2003) Mobile elements and mammalian genome evolution. Curr Opin Genet Dev 13: 651-658.
13. Belancio VP, Deininger PL, Roy-Engel AM, (2009) LINE dancing in the human genome: transposable elements and disease. Genome Med 1: 97.
14. Ostertag EM, Kazazian HH Jr, (2001) Biology of mammalian L1 retrotransposons. Annu Rev Genet 35: 501-538.
15. Prak NL, Haoudi A, (2006) LINE-1 Retrotransposition: Impact on Genome Stability and Diversity and Human Disease. J Biomed Biotechnol 2006: 37049.
16. Stetson DB, Ko JS, Heidmann T, Medzhitov R, (2008) Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
17. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, Mu Y, et al. (2009) L1 retrotransposition in human neural progenitor cells. Nature 460: 1127-1131.
18. Ergun S, Buschmann C, Heukeshoven J, Dammann K, Schnieders F, et al. (2004) Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem 279: 27753-27763.
19. Benihoud K, Bonardelle D, Soual-Hoebeke E, Durand-Gasselin I, Emilie D, et al. (2002) Unusual expression of LINE-1 transposable element in the MRL autoimmune lymphoproliferative syndrome-prone strain. Oncogene 21: 5593-5600.
20. Chiu YL, Greene WC, (2009) APOBEC3G: an intracellular centurion. Philos Trans R Soc Lond B Biol Sci 364: 689-703.
21. Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, et al. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A 103: 15588-15593.
22. Gourzi P, Leonova T, Papavasiliou FN, (2006) A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24: 779-786.
23. MacDuff DA, Demorest ZL, Harris RS, (2009) AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity. Nucleic Acids Res 37: 1854-1867.
24. Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV, Kazazian HH Jr, (2000) Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res 28: 1418-1423.
25. Krueger C, Danke C, Pfleiderer K, Schuh W, Jäck HM, et al. (2006) A gene regulation system with four distinct expression levels. J Gene Med 8: 1037-1047.
26. Lorens JB, Jang Y, Rossi AB, Payan DG, Bogenberger JM, (2000) Optimization of regulated LTR-mediated expression. Virology 272: 7-15.
27. Metzner M, Schuh W, Roth E, Jäck HM, Wabl M, (2010) Two forms of activation-induced cytidine deaminase differing in their ability to bind agarose. PLoS One 5: e8883.
28. Raiz J, Damert A, Chira S, Held U, Klawitter S, et al. (2012) The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res 40: 1666-1683.
29. Branciforte D, Martin SL, (1994) Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition. Mol Cell Biol 14: 2584-2592.
30. Martin SL, Branciforte D, (1993) Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol Cell Biol 13: 5383-5392.
31. Hayashi S, Yang J, Christenson L, Yanagimachi R, Hecht NB, (2003) Mouse preimplantation embryos developed from oocytes injected with round spermatids or spermatozoa have similar but distinct patterns of early messenger RNA expression. Biol Reprod 69: 1170-1176.
32. Lotscher M, Recher M, Lang KS, Navarini A, Hunziker L, et al. (2007) Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS One 2: e1158.
33. Dobigny G, Ozouf-Costaz C, Waters PD, Bonillo C, Coutanceau JP, et al. (2004) LINE-1 amplification accompanies explosive genome repatterning in rodents. Chromosome Res 12: 787-793.
34. Babushok DV, Kazazian HH Jr, (2007) Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat 28: 527-539.
35. Wallace N, Wagstaff BJ, Deininger PL, Roy-Engel AM, (2008) LINE-1 ORF1 protein enhances Alu SINE retrotransposition. Gene 419: 1-6.
36. Bransteitter R, Pham P, Scharff MD, Goodman MF, (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc Natl Acad Sci U S A 100: 4102-4107.
37. Nonaka T, Doi T, Toyoshima T, Muramatsu M, Honjo T, et al. (2009) Carboxy-terminal domain of AID required for its mRNA complex formation in vivo. Proc Natl Acad Sci U S A 106: 2747-2751.
38. Innerarity TL, Boren J, Yamanaka S, Olofsson SO, (1996) Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J Biol Chem 271: 2353-2356.
39. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, et al. (1995) Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81: 187-195.
40. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, et al. (1993) The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 268: 20709-20712.
41. Teng B, Burant CF, Davidson NO, (1993) Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260: 1816-1819.
42. Muramatsu M, Nagaoka H, Shinkura R, Begum NA, Honjo T, (2007) Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94: 1-36.
43. Farkash EA, Kao GD, Horman SR, Prak ET, (2006) Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Res 34: 1196-1204.
44. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139: 1069-1083.
45. Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, et al. (2004) Expression of the AID protein in normal and neoplastic B cells. Blood 104: 3318-3325.
46. Rada C, Jarvis JM, Milstein C, (2002) AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc Natl Acad Sci U S A 99: 7003-7008.
47. Petersen-Mahrt SK, Harris RS, Neuberger MS, (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418: 99-103.
48. Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, et al. (2003) Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422: 726-730.
49. Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, et al. (2005) Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435: 108-114.
50. Manis JP, Tian M, Alt FW, (2002) Mechanism and control of class-switch recombination. Trends Immunol 23: 31-39.
51. Suto A, Nakajima H, Hirose K, Suzuki K, Kagami S, et al. (2002) Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood 100: 4565-4573.
52. Rosenberg BR, Papavasiliou FN, (2007) Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. Adv Immunol 94: 215-244.
53. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK, (2004) Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 279: 52353-52360.
54. Schreck S, Buettner M, Kremmer E, Bogdan M, Herbst H, et al. (2006) Activation-induced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J Pathol 210: 26-31.
55. Hasler J, Rada C, Neuberger MS, (2011) Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1alpha (eEF1A). Proc Natl Acad Sci U S A 108: 18366-18371.
56. Chuang SM, Chen L, Lambertson D, Anand M, Kinzy TG, et al. (2005) Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A. Mol Cell Biol 25: 403-413.
57. Durandy A, Revy P, Fischer A, (2003) Hyper-immunoglobulin-M syndromes caused by an intrinsic B cell defect. Curr Opin Allergy Clin Immunol 3: 421-425.
58. Durandy A, Revy P, Imai K, Fischer A, (2005) Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 203: 67-79.
59. Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, et al. (2004) Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol 110: 22-29.
60. Chen L, Guo L, Tian J, Zheng B, Han S, (2010) Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background. Clin Exp Immunol 159: 169-175.
61. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, et al. (2002) Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298: 1424-1427.
62. Hase K, Takahashi D, Ebisawa M, Kawano S, Itoh K, et al. (2008) Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS One 3: e3033.
63. Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, et al. (2000) Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 97: 203-210.
64. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
65. Zhu Y, Nonoyama S, Morio T, Muramatsu M, Honjo T, et al. (2003) Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci 50: 41-46.
66. Beck-Engeser GB, Eilat D, Harrer T, Jack HM, Wabl M, (2009) Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. Proc Natl Acad Sci U S A 106: 20865-20870.
67. Beck-Engeser GB, Eilat D, Wabl M, (2011) An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 8: 91.
68. Loeb DD, Padgett RW, Hardies SC, Shehee WR, Comer MB, et al. (1986) The sequence of a large L1Md element reveals a tandemly repeated 5′ end and several features found in retrotransposons. Mol Cell Biol 6: 168-182.